WS #13403
Novo Nordisk reported Q2 adjusted operating profit up 11% and raised its full-year outlook, driven by GLP-1 volume growth, positive for the pharma sector.
Novo Nordisk Earnings and Outlook
Novo Nordisk reported Q2 adjusted operating profit up 11% and raised its full-year outlook, driven by GLP-1 volume growth, positive for the pharma sector.